<DOC>
	<DOCNO>NCT02432950</DOCNO>
	<brief_summary>This pilot clinical trial study pancreatic nutritional program help patient stage I-III breast cancer overweight obese lose weight . When patient high level sugar blood , due eat sugary food and/or sedentary lifestyle , pancreas need work harder digest sugar . This cause weight gain , obesity , illness . Breast cancer patient overweight obese likely breast cancer return . The pancreatic nutritional program diet lifestyle intervention help protect pancreas keep blood sugar level low , may help patient achieve sustain weight loss , improve health , good quality life , possibly well outcome treatment .</brief_summary>
	<brief_title>Pancreatic Nutritional Program Weight Loss Overweight/Obese Patients With Stage I-III Breast Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To estimate change body weight 6 month post-intervention relative baseline . SECONDARY OBJECTIVES : I . To examine change : body composition ; body chemistry ; physical fitness ; inflammatory marker ; deoxyribonucleic acid ( DNA ) repair capacity ; quality life per Functional Assessment Cancer Therapy - Breast ( FACT-B ) +4 , version 4 questionnaire 6 month post-intervention relative baseline . II . To describe adverse event possibly relate wearing glucometer sensor follow pancreatic nutritional program ( PNP ) diet . III . To document compliance various component PNP ( wear glucometer sensor ; record body weight ; complete journal entry ; complete meal card ; attend weekly counseling session diet instructor ) . OUTLINE : Patients participate PNP intervention , begin baseline meeting diet lifestyle instructor discus baseline test result , begin educational plan , determine individualize eating plan , print food choice . Patients also undergo automated glucometry every 15 minute , review individual food choice blood glucose level 90 minute eat , keep daily nutrition lifestyle journal log , fill daily meal discovery card log , attend weekly meeting diet lifestyle instructor 12 week . After completion study , patient follow within 1 week 6 month .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<criteria>Patients earlystage breast cancer ( stage IIII ) Patients undergone chemotherapy eligible ; patient undergone chemotherapy must complete adjuvant chemotherapy &gt; = 3 month = &lt; 5 year prior study enrollment Postmenopausal woman define either : natural menopause least one year since last menses , chemotherapyinduced menopause least one year since last menses folliclestimulating hormone ( FSH ) estradiol level within postmenopausal range Body mass index ( BMI ) 2533 kg/m^2 Patients must willing adhere PNP intervention entire 6month study All patient must ability willingness sign write informed consent Patients diabetic Patients whose BMI fall outside eligible range ( &lt; 25 kg/m^2 &gt; 33 kg/m^2 ) Patients stage IV breast cancer Patients Rheumatoid Arthritis inflammatory disease would impact correlative study</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>